Arsheeta Kumar

Apr 17, 2024 | pharmacytimes.com | Grace Baek |Arsheeta Kumar |Chloe Siu

April 17, 2024Pharmacy Practice in Focus: OncologyApril 2024This review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia. PrécisThis review discusses the prevalence, mechanisms of development, and evolving treatment landscape in chronic lymphocytic leukemia, highlighting the emergence of Bruton tyrosine kinase inhibitors in 2013 as improved treatment options over traditional chemoimmunotherapy.